Mankind Pharma Limited has announced the appointment of Mr. Anish Vanraj Bafna as an Additional Director, designated as a Non-Executive Independent Director. This appointment, effective from August 10, 2026, is for a term of five consecutive years, subject to shareholder approval via postal ballot. Mr. Bafna brings over 30 years of extensive experience in the healthcare and medical devices sector to the board, significantly bolstering the company’s governance and strategic direction.
Board Meeting Highlights Key Appointment
Mankind Pharma Limited’s Board of Directors, in a meeting held on Monday, August 10, 2026, has approved the appointment of Mr. Anish Vanraj Bafna as an Additional Director. Mr. Bafna will serve as a Non-Executive Independent Director, a role that officially commences on August 10, 2026. This strategic appointment was made based on the recommendation of the Nomination and Remuneration Committee.
Appointment Details and Shareholder Approval
The appointment of Mr. Bafna is for a term of five consecutive years. To formalize this, a Postal Ballot Notice will be circulated to the company’s members seeking their approval. The board has also confirmed that Mr. Bafna is not debarred from holding a directorship by any regulatory authority, adhering to necessary declarations.
Mr. Bafna’s Extensive Industry Experience
Mr. Anish Vanraj Bafna brings a wealth of experience, exceeding 30 years, in the healthcare and medical devices industry. His career includes significant leadership roles, such as former Chief Executive Officer and Managing Director of Healthium Medtech Limited, where he was instrumental in driving growth and global expansion. He also held key positions at Baxter International, serving as President – Japan and Regional Head – Emerging Asia. Mr. Bafna holds a Bachelor’s Degree in Science (Chemistry) and a Post Graduate Diploma in Management (PGDM). He has confirmed that he has no promoter or related-party relationships within Mankind Pharma and meets all independence criteria.
Board Meeting Conduct
The Board Meeting took place on August 10, 2026, commencing at 03:30 p.m. IST and concluding at 03:45 p.m. IST.
Source: BSE
